Dealings in securities by directors of the company and by the company secretary and a director of a major subsidiary Mediclinic International Limited (Incorporated in the Republic of South Africa) (Registration number: 1983/010725/06) ISIN: ZAE000074142 JSE Share Code: MDC NSX Share Code: MCI ("Mediclinic" or “the Company”) DEALINGS IN SECURITIES BY DIRECTORS OF THE COMPANY AND BY THE COMPANY SECRETARY AND A DIRECTOR OF A MAJOR SUBSIDIARY In compliance with the Listings Requirements of the JSE Limited (“JSE”), the following information is disclosed relating to the sale of ordinary shares in Mediclinic by directors of the Company and a major subsidiary: Director : Mr D P Meintjes Company : Mediclinic International Limited Date of transaction : 13 February 2015 Nature of transaction : On market sale of securities Class of securities : Ordinary shares Number of securities : 25 000 Selling price : VWAP: R126.8992 per share Lowest price: R124.76 per share Highest price: R129.50 per share Total value of transaction : R3 172 480.00 Nature of interest : Direct beneficial Director : Mr C I Tingle Company : Mediclinic International Limited Date of transaction : 13 February 2015 Nature of transaction : On market sale of securities Class of securities : Ordinary shares Number of securities : 25 000 Selling price : VWAP: R126.8992 per share Lowest price: R124.76 per share Highest price: R129.50 per share Total value of transaction : R3 172 480.00 Nature of interest : Direct beneficial Director : Mr G C Hattingh (Company Secretary) Company : Mediclinic International Limited Date of transaction : 13 February 2015 Nature of transaction : On market sale of securities Class of securities : Ordinary shares Number of securities : 5 000 Selling price : 3 250 at R127.80 per share 1 750 at R127.81 per share Total value of transaction : R639 017.50 Nature of interest : Indirect beneficial Director : Ms L Heerink-Smit (Company Secretary) Company : Mediclinic Investments (Pty) Ltd (major subsidiary of Mediclinic International Limited) Date of transaction : 13 February 2015 Nature of transaction : On market sale of securities Class of securities : Ordinary shares Number of securities : 2 374 Selling price : R128.00 per share Total value of transaction : R303 872.00 Nature of interest : Direct beneficial Clearance was obtained for these transactions as required by the JSE Listings Requirements. Stellenbosch 16 February 2015 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 16/02/2015 10:34:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.